Sleep Apnea Diagnostic and Therapeutic Devices Worldwide

Abstract

Report Benefits

This report can help in:

• Assessing the market for Sleep Apnea Diagnostic and Therapeutic Devices worldwide, growth segments, and growth regions.
• Understanding market drivers and restraints, market segmentation, and competitive segmentation.
• Strategic planning and competitive strategy.
• Identifying opportunities for partnerships and alliances.

Key Takeaways

• The total US market for sleep apnea diagnostic and therapy devices is estimated to have been $1.12 billion in revenues in 2007, growing to $2.92 billion by the end of 2014 at a CAGR of 14.7 percent.
• Focus of product innovation is on development of more economical, wireless, portable, easy-to-use monitors for screening and PAP-based treatment devices for OSA and other types of sleep apnea.
• Other innovations include more comfortable facial interfaces and features of CPAP devices such as less noisy machines with long battery life..
• Type Iand II monitors for sleep apnea diagnosis are the most commonly used in the US. New CMS reimbursement will open up the market to Type III devices for home testing.